Tag Archives: BIO International Convention

Liking, Sharing, and Tweeting to Better Health

BIO2014 Panel

Making an impact online goes beyond having a Facebook page. Helping to open the 2014 BIO International Convention, Amy O’Conner, Director, Digital Government Affairs with Eli Lilly and Company, joined Chief Marketing Officer at POPVOX, Rachna Choudhry; Twitter’s Head of Healthcare, Jeremy Anderson; and Chief Strategist at Pure Communications, Mike Huckman, to discuss how social media can empower individuals and patient advocates to improve the future of health care. O’Conner writes: “Part of what makes Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

The Journey from the Bench to Bedside

shutterstock_2103563

A partnership between a leading academic research center and a biologics company is aiming to develop new therapeutic opportunities Translational research enables therapies get to where they need to be – to the patient. The process is characterized by collaborative activity between university and company scientists. One recent example is the announcement of a three-year collaboration between MedImmune, the global biologics research and development arm of AstraZeneca, and the Clinical and Translational Science Institute (CTSI) Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

From Participant to Judge in the International BioGENEius Challenge

Sagar

My name is Sagar Rambhia, and I participated in the 2011 International BioGENEius Challenge. Three years later, I have come back to be a judge at the 2014 International BioGENEius Challenge. I am 19 years old, and since competing in the 2011 BioGENEius Challenge, I have started my own company and continued to conduct biomedical engineering research. Back in 2011, as part of the BioGENEius Challenge, I was given the life-changing opportunity to present my Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Delivering the Right Dose, Less Often

medical_research

Biologics are a growing area of drug development, including life-threatening and life-changing disorders such as cancer and rheumatoid arthritis. However, many biologics have short half-lives, and need to be dosed daily. To make them more convenient to use, as well as safer and more effective, researchers are developing delivery systems that keep the biologics in the body for longer, reducing the frequency of dosing. Swedish company Affibody is using the natural affinity of a naturally-occurring Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

In Memory of Sandi Dennis

inthememoryof

Last September, BIO and the industry lost a dear friend and one of the nation’s top regulatory attorneys – Sandi Dennis – after a long battle with cancer. Sandi served as the deputy general counsel for healthcare at BIO. She focused on educating biotechnology companies about emerging legal and policy issues affecting the development of ground-breaking new medicines, and advocating on their behalf with Congress and executive agencies to help expedite the approval of treatments Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,